Antidepressant-like effects of Ashwagandha (Withania Somnifera) on chronic unpredictable mild stress-induced depression in adolescent rats
- PMID: 40560204
- DOI: 10.1007/s00213-025-06844-5
Antidepressant-like effects of Ashwagandha (Withania Somnifera) on chronic unpredictable mild stress-induced depression in adolescent rats
Abstract
Rationale: Adolescent depression is often linked to biological changes associated with stress. However, new approaches and treatment strategies for early intervention and prevention of depression in children and adolescents are still limited. Ashwagandha is an Ayurvedic herb widely used in the management of anxiety and stress. However, there is no information in the current literature on its potential effect on adolescent depression.
Objectives: This study aimed to investigate the effects of depression on proapoptotic proteins and neuroinflammation and the antidepressant effect of Ashwagandha on depression-like symptoms in adolescent rats exposed to the Chronic Unpredictable Mild Stress (CUMS) model.
Methods: In the study, CUMS model was used to induce depression in adolescent rats. Rats were treated with Ashwagandha or Sertraline. To evaluate the antidepressant effects, behavioral tests as well as biochemical and histological analyses were performed. Forced Swim Test (FST), Sucrose Test and Elevated Plus Maze Test were performed as behavioral tests. Brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were measured by the ELISA method in the fronto-parietal cortex. Proapoptotic proteins (Bax and Caspase-3) and inflammatory markers (TNF-α and IL-1β), as well as glial fibrillary acidic protein (GFAP), were evaluated immunohistochemically in the fronto-parietal cortex.
Results: Proapoptotic proteins (Bax and Caspase-3) and inflammatory markers (TNF-α and IL-1β) were increased in the CUMS group. BDNF and GFAP levels were decreased. Ashwagandha treatment was more effective than Sertraline in reducing the levels of these proteins and markers. Additionally, Ashwagandha prevented weight loss.
Conclusions: Ashwagandha showed antidepressant-like effects in adolescent rats, reducing apoptosis, inflammation, and neuroinflammation, suggesting potential for treating adolescent depression.
Keywords: Adolescent depression; Ashwagandha; CUMS; GFAP; Proapoptotic proteins; Sertraline.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Competing interests: The authors have no competing interests to declare that are relevant to the content of this article. Financial interests: The authors declare they have no financial interests.
Similar articles
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
Quercetin alleviates depression in CUMS rats via modulating immune plasticity in the choroid plexus to inhibit hippocampal microglial activation.Eur J Pharmacol. 2025 Sep 15;1003:177860. doi: 10.1016/j.ejphar.2025.177860. Epub 2025 Jun 26. Eur J Pharmacol. 2025. PMID: 40581279
-
New generation antidepressants for depression in children and adolescents: a network meta-analysis.Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Cochrane Database Syst Rev. 2021. PMID: 34029378 Free PMC article.
-
Psychological and/or educational interventions for the prevention of depression in children and adolescents.Cochrane Database Syst Rev. 2004;(1):CD003380. doi: 10.1002/14651858.CD003380.pub2. Cochrane Database Syst Rev. 2004. Update in: Cochrane Database Syst Rev. 2011 Dec 07;(12):CD003380. doi: 10.1002/14651858.CD003380.pub3. PMID: 14974014 Updated.
-
E-Health interventions for anxiety and depression in children and adolescents with long-term physical conditions.Cochrane Database Syst Rev. 2018 Aug 15;8(8):CD012489. doi: 10.1002/14651858.CD012489.pub2. Cochrane Database Syst Rev. 2018. PMID: 30110718 Free PMC article.
References
-
- Alleva E, Aloe L, Cirulli F, Della Seta D, Tirassa P (1996) Serum NGF levels increase during lactation and following maternal aggression in mice. Physiol Behav 59(3):461–466. https://doi.org/10.1016/0031-9384(95)02083-7 - DOI - PubMed
-
- Araya-Callis C, Hiemke C, Abumaria N, Flugge G (2012) Chronic psychosocial stress and Citalopram modulate the expression of the glial proteins GFAP and NDRG2 in the hippocampus. Psychopharmacology 224(1):209–222. https://doi.org/10.1007/s00213-012-2741-x - DOI - PubMed - PMC
-
- Aricioglu F, Ozkartal CS, Bastaskin T, Tüzün E, Kandemir C, Sirvanci S, Kucukali CI, Utkan T (2019) Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats. Clin Psychopharmacol Neurosci. 17(2):261–272. https://doi.org/10.9758/cpn.2019.17.2.261 - DOI - PubMed - PMC
-
- Aykaç A, Süer K, Taşkıran C (2015) Anksiyete Araştırmalarında Kullanılan Sıçan Davranış modelleri. Marmara Med J 28(1):1–7. https://doi.org/10.5472/MMJ.2015.03661.1 - DOI
-
- Banasr M, Chowdhury GM, Terwilliger R, Newton SS, Duman RS, Behar KL, Sanacora G (2010) Glial pathology in an animal model of depression: reversal of stress-induced cellular, metabolic and behavioral deficits by the glutamate-modulating drug riluzole. Mol Psychiatry 15(5):501–511. https://doi.org/10.1038/mp.2008.106 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous